| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biopsy, Fine-Needle | 14 | 2022 | 698 | 1.850 |
Why?
|
| In Situ Hybridization, Fluorescence | 18 | 2017 | 2313 | 1.340 |
Why?
|
| Biopsy, Needle | 27 | 2006 | 1389 | 1.000 |
Why?
|
| Cytodiagnosis | 8 | 2020 | 222 | 0.740 |
Why?
|
| Lymphoma, Mantle-Cell | 5 | 2018 | 749 | 0.710 |
Why?
|
| Lymph Nodes | 7 | 2020 | 3076 | 0.700 |
Why?
|
| Urinary Bladder Neoplasms | 7 | 2017 | 2431 | 0.630 |
Why?
|
| Biopsy, Large-Core Needle | 2 | 2018 | 139 | 0.620 |
Why?
|
| Mediastinal Neoplasms | 2 | 2019 | 427 | 0.590 |
Why?
|
| Lymphoma | 4 | 2015 | 1522 | 0.560 |
Why?
|
| Chromosome Aberrations | 6 | 2008 | 2032 | 0.560 |
Why?
|
| Image Cytometry | 6 | 2008 | 46 | 0.490 |
Why?
|
| Mediastinum | 2 | 2019 | 276 | 0.470 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 880 | 0.430 |
Why?
|
| Granular Cell Tumor | 1 | 2012 | 22 | 0.410 |
Why?
|
| Thyroid Neoplasms | 6 | 2012 | 1878 | 0.410 |
Why?
|
| Thyroid Gland | 3 | 2012 | 368 | 0.400 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2013 | 2475 | 0.400 |
Why?
|
| Urothelium | 2 | 2010 | 264 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2008 | 325 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2008 | 413 | 0.320 |
Why?
|
| Vaginal Smears | 3 | 2008 | 183 | 0.320 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2011 | 382 | 0.300 |
Why?
|
| Carcinoma | 5 | 2005 | 2611 | 0.300 |
Why?
|
| Kidney Neoplasms | 5 | 2014 | 3114 | 0.300 |
Why?
|
| Sensitivity and Specificity | 10 | 2015 | 5182 | 0.290 |
Why?
|
| Urinary Diversion | 1 | 2007 | 86 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2005 | 287 | 0.280 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2018 | 2456 | 0.280 |
Why?
|
| Vaginal Neoplasms | 1 | 2008 | 154 | 0.280 |
Why?
|
| Immunophenotyping | 6 | 2018 | 1730 | 0.280 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 3 | 2022 | 166 | 0.260 |
Why?
|
| Flow Cytometry | 8 | 2018 | 3070 | 0.260 |
Why?
|
| Carcinoma, Small Cell | 2 | 1998 | 428 | 0.260 |
Why?
|
| Ploidies | 2 | 2005 | 256 | 0.250 |
Why?
|
| Sickle Cell Trait | 1 | 2005 | 24 | 0.250 |
Why?
|
| Aged | 38 | 2019 | 73259 | 0.250 |
Why?
|
| Middle Aged | 42 | 2019 | 90230 | 0.240 |
Why?
|
| Male | 48 | 2019 | 128437 | 0.240 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 4 | 2022 | 1737 | 0.230 |
Why?
|
| Coccidioides | 1 | 2003 | 8 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2008 | 5601 | 0.230 |
Why?
|
| Lymphocytes | 5 | 2018 | 1275 | 0.220 |
Why?
|
| Coccidioidomycosis | 1 | 2003 | 33 | 0.220 |
Why?
|
| Female | 46 | 2019 | 148810 | 0.220 |
Why?
|
| Adult | 35 | 2019 | 81883 | 0.220 |
Why?
|
| Image-Guided Biopsy | 2 | 2019 | 337 | 0.220 |
Why?
|
| Humans | 72 | 2022 | 270896 | 0.220 |
Why?
|
| Carcinoma, Medullary | 1 | 2005 | 248 | 0.210 |
Why?
|
| Lung Neoplasms | 12 | 2015 | 12022 | 0.210 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2006 | 318 | 0.210 |
Why?
|
| Urinary Bladder | 2 | 2005 | 593 | 0.210 |
Why?
|
| Aged, 80 and over | 16 | 2019 | 31000 | 0.210 |
Why?
|
| Translocation, Genetic | 2 | 2005 | 1286 | 0.200 |
Why?
|
| Diagnosis, Differential | 10 | 2011 | 4862 | 0.200 |
Why?
|
| Epithelial Cells | 2 | 2008 | 1872 | 0.200 |
Why?
|
| Hodgkin Disease | 2 | 2007 | 1486 | 0.190 |
Why?
|
| Biomarkers, Tumor | 7 | 2017 | 10702 | 0.190 |
Why?
|
| Lymphoma, T-Cell | 3 | 2015 | 368 | 0.190 |
Why?
|
| Ki-67 Antigen | 2 | 2018 | 680 | 0.190 |
Why?
|
| Lymphoma, B-Cell | 5 | 2015 | 932 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2012 | 10366 | 0.180 |
Why?
|
| Osteomyelitis | 1 | 2003 | 258 | 0.180 |
Why?
|
| Bronchoscopy | 2 | 2015 | 482 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2010 | 5566 | 0.170 |
Why?
|
| Cell Nucleus | 7 | 2012 | 1721 | 0.160 |
Why?
|
| Cyclin D1 | 3 | 2018 | 591 | 0.160 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2008 | 1914 | 0.160 |
Why?
|
| DNA | 3 | 2005 | 3056 | 0.150 |
Why?
|
| Neoplasm Staging | 9 | 2019 | 14006 | 0.140 |
Why?
|
| Kidney | 1 | 2005 | 2124 | 0.140 |
Why?
|
| Soft Tissue Neoplasms | 2 | 1994 | 916 | 0.140 |
Why?
|
| Staining and Labeling | 3 | 2005 | 450 | 0.140 |
Why?
|
| Splenic Neoplasms | 1 | 1997 | 124 | 0.130 |
Why?
|
| Immunohistochemistry | 8 | 2015 | 7726 | 0.130 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1995 | 22 | 0.130 |
Why?
|
| Ultrasonography | 2 | 2019 | 1934 | 0.130 |
Why?
|
| Aurora Kinase A | 1 | 2017 | 210 | 0.130 |
Why?
|
| Prognosis | 12 | 2018 | 22495 | 0.130 |
Why?
|
| Seminoma | 1 | 1995 | 88 | 0.120 |
Why?
|
| Spleen | 1 | 1997 | 725 | 0.120 |
Why?
|
| Carcinoma, Transitional Cell | 3 | 2010 | 999 | 0.120 |
Why?
|
| Lymphatic Diseases | 1 | 1995 | 128 | 0.120 |
Why?
|
| Centrosome | 2 | 2005 | 106 | 0.120 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1997 | 559 | 0.110 |
Why?
|
| Lymphoma, Follicular | 3 | 2004 | 636 | 0.110 |
Why?
|
| Bronchi | 1 | 2015 | 326 | 0.110 |
Why?
|
| Myxoma | 1 | 1994 | 68 | 0.110 |
Why?
|
| Neoplasm Metastasis | 3 | 2006 | 5309 | 0.110 |
Why?
|
| Parvovirus B19, Human | 1 | 2013 | 40 | 0.110 |
Why?
|
| Parvoviridae Infections | 1 | 2013 | 41 | 0.110 |
Why?
|
| Muscular Diseases | 1 | 1994 | 161 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2018 | 7250 | 0.110 |
Why?
|
| Reproducibility of Results | 4 | 2011 | 6204 | 0.100 |
Why?
|
| CD5 Antigens | 2 | 2011 | 130 | 0.100 |
Why?
|
| Thyroid Diseases | 1 | 1993 | 87 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2014 | 2392 | 0.100 |
Why?
|
| Forecasting | 1 | 2015 | 705 | 0.100 |
Why?
|
| Interphase | 4 | 2005 | 156 | 0.100 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 1996 | 446 | 0.100 |
Why?
|
| Salivary Gland Neoplasms | 1 | 1996 | 499 | 0.100 |
Why?
|
| Retrospective Studies | 13 | 2022 | 39750 | 0.100 |
Why?
|
| Receptors, IgE | 1 | 2011 | 43 | 0.090 |
Why?
|
| Abdominal Neoplasms | 1 | 1993 | 250 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 5249 | 0.090 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2011 | 71 | 0.090 |
Why?
|
| Urine | 2 | 2005 | 138 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 1824 | 0.090 |
Why?
|
| Testicular Neoplasms | 1 | 1995 | 562 | 0.090 |
Why?
|
| Predictive Value of Tests | 7 | 2012 | 4962 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 2666 | 0.090 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2011 | 150 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2013 | 453 | 0.090 |
Why?
|
| CD3 Complex | 1 | 2011 | 320 | 0.090 |
Why?
|
| Follow-Up Studies | 6 | 2012 | 15223 | 0.080 |
Why?
|
| Penicillins | 1 | 1989 | 169 | 0.080 |
Why?
|
| S-Phase Kinase-Associated Proteins | 2 | 2005 | 53 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 771 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 3 | 2006 | 1196 | 0.070 |
Why?
|
| Fenretinide | 1 | 2008 | 100 | 0.070 |
Why?
|
| Endosonography | 1 | 2011 | 550 | 0.070 |
Why?
|
| DNA, Neoplasm | 3 | 2003 | 1964 | 0.070 |
Why?
|
| False Negative Reactions | 2 | 2001 | 295 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 1 | 1989 | 404 | 0.070 |
Why?
|
| 14-3-3 Proteins | 1 | 2007 | 142 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2015 | 1698 | 0.070 |
Why?
|
| Prostatic Neoplasms | 2 | 2006 | 5854 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 1989 | 318 | 0.070 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2005 | 15 | 0.070 |
Why?
|
| Lewis X Antigen | 1 | 2005 | 38 | 0.070 |
Why?
|
| Chemotactic Factors | 1 | 2005 | 42 | 0.060 |
Why?
|
| Microvilli | 1 | 2005 | 89 | 0.060 |
Why?
|
| Lymphoid Tissue | 1 | 2005 | 102 | 0.060 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2010 | 638 | 0.060 |
Why?
|
| Postal Service | 1 | 2005 | 17 | 0.060 |
Why?
|
| Carcinoma, Ductal | 1 | 2006 | 144 | 0.060 |
Why?
|
| Cell Biology | 1 | 2005 | 17 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 242 | 0.060 |
Why?
|
| Gene Dosage | 2 | 2006 | 824 | 0.060 |
Why?
|
| S100 Proteins | 1 | 2005 | 188 | 0.060 |
Why?
|
| Telomerase | 1 | 2008 | 547 | 0.060 |
Why?
|
| Hematuria | 1 | 2005 | 84 | 0.060 |
Why?
|
| Tissue Fixation | 1 | 2005 | 139 | 0.060 |
Why?
|
| RNA, Viral | 1 | 2007 | 729 | 0.060 |
Why?
|
| Keratins | 1 | 2005 | 340 | 0.060 |
Why?
|
| Vimentin | 1 | 2005 | 255 | 0.060 |
Why?
|
| Necrosis | 1 | 2006 | 599 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1654 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 488 | 0.060 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 5150 | 0.060 |
Why?
|
| Cytological Techniques | 1 | 2004 | 74 | 0.060 |
Why?
|
| Mitotic Index | 1 | 2004 | 164 | 0.060 |
Why?
|
| Adolescent | 10 | 2012 | 32722 | 0.060 |
Why?
|
| Cystectomy | 1 | 2007 | 632 | 0.060 |
Why?
|
| Gene Rearrangement | 3 | 2002 | 815 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 1 | 2007 | 959 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2003 | 189 | 0.050 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2007 | 480 | 0.050 |
Why?
|
| Oncogenes | 1 | 2006 | 700 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2002 | 130 | 0.050 |
Why?
|
| Aneuploidy | 2 | 2003 | 377 | 0.050 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2008 | 743 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2002 | 240 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 1996 | 4138 | 0.050 |
Why?
|
| RNA Interference | 1 | 2005 | 1387 | 0.050 |
Why?
|
| Chromosome Fragility | 1 | 2000 | 33 | 0.050 |
Why?
|
| Nephrectomy | 1 | 2005 | 799 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2005 | 1473 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2005 | 7784 | 0.040 |
Why?
|
| Chromosome Breakage | 1 | 2000 | 225 | 0.040 |
Why?
|
| Melanoma | 2 | 1994 | 5596 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 4804 | 0.040 |
Why?
|
| Ascitic Fluid | 2 | 1996 | 84 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 2357 | 0.040 |
Why?
|
| Perineum | 1 | 1998 | 116 | 0.040 |
Why?
|
| United States | 1 | 2015 | 15887 | 0.040 |
Why?
|
| Neurofibroma | 1 | 1997 | 32 | 0.040 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 1998 | 172 | 0.030 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2003 | 1067 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 9041 | 0.030 |
Why?
|
| Cystadenocarcinoma, Papillary | 1 | 1996 | 82 | 0.030 |
Why?
|
| Rectum | 1 | 1998 | 479 | 0.030 |
Why?
|
| Vacuoles | 1 | 1995 | 45 | 0.030 |
Why?
|
| Neurilemmoma | 1 | 1997 | 133 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1544 | 0.030 |
Why?
|
| Mitosis | 1 | 1998 | 689 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 1999 | 570 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 1995 | 92 | 0.030 |
Why?
|
| Neoplasms, Mesothelial | 1 | 1994 | 6 | 0.030 |
Why?
|
| Urogenital Neoplasms | 1 | 1996 | 116 | 0.030 |
Why?
|
| Bone and Bones | 1 | 1998 | 607 | 0.030 |
Why?
|
| Pancreas | 1 | 1998 | 745 | 0.030 |
Why?
|
| Antigens, CD19 | 2 | 2010 | 583 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3350 | 0.030 |
Why?
|
| Myoepithelioma | 1 | 1994 | 32 | 0.030 |
Why?
|
| Pleural Effusion | 1 | 1995 | 217 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1995 | 704 | 0.030 |
Why?
|
| Parotid Neoplasms | 1 | 1994 | 152 | 0.030 |
Why?
|
| Thyroidectomy | 2 | 2012 | 491 | 0.030 |
Why?
|
| Optic Disk | 1 | 2013 | 54 | 0.030 |
Why?
|
| Papanicolaou Test | 1 | 1993 | 130 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1993 | 379 | 0.030 |
Why?
|
| Neoplasms | 1 | 1998 | 15891 | 0.020 |
Why?
|
| Adenocarcinoma | 3 | 2006 | 7920 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 14808 | 0.020 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2012 | 131 | 0.020 |
Why?
|
| Axilla | 1 | 1994 | 934 | 0.020 |
Why?
|
| Transfection | 2 | 2007 | 3119 | 0.020 |
Why?
|
| Neck Dissection | 1 | 2012 | 294 | 0.020 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 1993 | 222 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 2198 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 1997 | 4959 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 1693 | 0.020 |
Why?
|
| Disease Progression | 2 | 2017 | 6841 | 0.020 |
Why?
|
| Karyotyping | 2 | 2003 | 1065 | 0.020 |
Why?
|
| Leukocyte Common Antigens | 1 | 2010 | 191 | 0.020 |
Why?
|
| Oxacillin | 1 | 1989 | 7 | 0.020 |
Why?
|
| Bone Marrow | 2 | 2013 | 2441 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2010 | 6258 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 2477 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 1996 | 855 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 2476 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 424 | 0.020 |
Why?
|
| Apoptosis | 2 | 2005 | 7763 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 3345 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 615 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 1341 | 0.020 |
Why?
|
| Liver | 1 | 1998 | 3086 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2006 | 5762 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 1077 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 1993 | 612 | 0.020 |
Why?
|
| Sputum | 1 | 2008 | 158 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2010 | 6231 | 0.020 |
Why?
|
| Administration, Intravesical | 1 | 2008 | 169 | 0.020 |
Why?
|
| Coma | 1 | 1987 | 63 | 0.020 |
Why?
|
| Neck Injuries | 1 | 1987 | 37 | 0.020 |
Why?
|
| Brain Death | 1 | 1987 | 59 | 0.020 |
Why?
|
| Recurrence | 3 | 2005 | 4870 | 0.020 |
Why?
|
| Lung | 1 | 1998 | 3297 | 0.020 |
Why?
|
| Placebos | 1 | 2008 | 443 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 2185 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2006 | 56 | 0.020 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2006 | 27 | 0.020 |
Why?
|
| Age Factors | 2 | 2012 | 5487 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 1830 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2012 | 6786 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 209 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 190 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2012 | 9469 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 206 | 0.020 |
Why?
|
| Cell Division | 2 | 2004 | 2678 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1989 | 1070 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2008 | 9303 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 14628 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 22180 | 0.020 |
Why?
|
| Biopsy | 1 | 1993 | 3500 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2012 | 2254 | 0.020 |
Why?
|
| ROC Curve | 1 | 2008 | 1250 | 0.020 |
Why?
|
| BCG Vaccine | 1 | 2008 | 425 | 0.010 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 758 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 1989 | 794 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1995 | 2634 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1052 | 0.010 |
Why?
|
| Tubulin | 1 | 2003 | 202 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2006 | 767 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 521 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2003 | 299 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2006 | 1027 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 2091 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2003 | 313 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2007 | 2425 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1997 | 7917 | 0.010 |
Why?
|
| DNA Probes | 1 | 2000 | 248 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 1134 | 0.010 |
Why?
|
| Cisplatin | 1 | 2007 | 2499 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2007 | 4348 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 2142 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 1723 | 0.010 |
Why?
|
| Cell Nucleolus | 1 | 1998 | 101 | 0.010 |
Why?
|
| Texas | 1 | 1989 | 6440 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 4331 | 0.010 |
Why?
|
| Mice | 2 | 2010 | 35624 | 0.010 |
Why?
|
| Child | 2 | 2001 | 30549 | 0.010 |
Why?
|
| Phenotype | 2 | 2001 | 6494 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 5092 | 0.010 |
Why?
|
| Time Factors | 2 | 2005 | 13023 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 460 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 2546 | 0.010 |
Why?
|
| Cell Size | 1 | 1996 | 142 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 3487 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2000 | 1426 | 0.010 |
Why?
|
| Genomics | 1 | 2006 | 2825 | 0.010 |
Why?
|
| Brain | 1 | 1987 | 4227 | 0.010 |
Why?
|
| Actin Cytoskeleton | 1 | 1994 | 78 | 0.010 |
Why?
|
| Animals | 2 | 2010 | 62186 | 0.010 |
Why?
|
| Infant | 1 | 1989 | 13970 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 710 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 10257 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 13377 | 0.010 |
Why?
|
| Pelvic Neoplasms | 1 | 1994 | 201 | 0.010 |
Why?
|
| Survival Rate | 1 | 2006 | 12515 | 0.010 |
Why?
|
| Chromatin | 1 | 1998 | 1043 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 4141 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1994 | 424 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1994 | 607 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1994 | 16212 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1993 | 531 | 0.000 |
Why?
|
| Hypoxia, Brain | 1 | 1987 | 36 | 0.000 |
Why?
|
| Neurologic Examination | 1 | 1987 | 264 | 0.000 |
Why?
|
| Endometrial Neoplasms | 1 | 1994 | 1385 | 0.000 |
Why?
|
| Brain Ischemia | 1 | 1987 | 311 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1987 | 1000 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 1994 | 4786 | 0.000 |
Why?
|
| Risk Factors | 1 | 1994 | 17867 | 0.000 |
Why?
|